Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(3.20)
# 1,125
Out of 4,735 analysts
27
Total ratings
58.33%
Success rate
11.34%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYEN Eyenovia | Downgrades: Neutral | n/a | $0.06 | - | 1 | Nov 18, 2024 | |
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $367.97 | -6.51% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $10.19 | +425.02% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $29.86 | +33.96% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $13.62 | +120.26% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $4.91 | +73.12% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $7.90 | +102.53% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $4.00 | +26,675.00% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $17 → $23 | $0.44 | +5,140.37% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $4.60 | +1,008.70% | 1 | Dec 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $8.20 | +95.12% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $4.76 | +845.38% | 1 | Jan 22, 2020 |
Eyenovia
Nov 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.06
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $367.97
Upside: -6.51%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $10.19
Upside: +425.02%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $29.86
Upside: +33.96%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $13.62
Upside: +120.26%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $4.91
Upside: +73.12%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $7.90
Upside: +102.53%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $4.00
Upside: +26,675.00%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $0.44
Upside: +5,140.37%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $4.60
Upside: +1,008.70%
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $8.20
Upside: +95.12%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $4.76
Upside: +845.38%